Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Finch Therapeutics Group, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 43 | 40 | −3 |
| Shares | 10.0M | 9.59M | −451.9K (−4.5%) |
| Value | $16.8M | $4.60M | −$12.2M (−72.6%) |
New holders (2)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 12,545 | $6.00K | 0.00% |
| Group One Trading, L.P. | 200 | $96 | 0.00% |
Sold out (5)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Aperture Investors, LLC | 192,794 | $322.0K |
| SCS Capital Management LLC | 38,294 | $64.0K |
| Virtu Financial LLC | 15,190 | $25.0K |
| Dimensional Fund Advisors LP | 10,037 | $17.0K |
| Royal Bank of Canada | 160 | $0 |